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How	the	UK’s	trade	deals	will	impact	healthcare
access	across	Europe
How	might	the	negotiations	over	the	future	UK-EU	relationship	affect	healthcare	access?	Drawing	on
a	new	research	briefing,	Matt	Wood	provides	a	detailed	assessment	of	the	impact	UK-EU	and	UK-US
trade	agreements	may	have	on	healthcare	across	Europe.
Protecting	health	and	healthcare	was	one	of	the	key	issues	during	the	EU	referendum	in	2016,	and
now,	with	the	coronavirus	crisis	still	ongoing,	it	is	a	crucial	part	of	the	trade	negotiations.	Our
new	research	briefing	for	UK	in	a	Changing	Europe	suggests	the	need	for	greater	transparency	to	show	the
implications	of	the	current	UK-EU	and	UK-US	trade	negotiations	for	the	NHS,	and	for	health	more	generally.
The	briefing	shows	equitable	healthcare	access	as	a	core	public	value	is	up	for	grabs,	with	differing	commitments	to
high	regulatory	standards	and	private	sector	involvement	in	healthcare	evident	in	the	UK,	EU	and	US	negotiating
positions.	Our	report	covers	a	range	of	areas	where	positions	between	the	negotiating	partners	diverge,	but
particularly	important	in	light	of	Covid-19	are	the	possible	impacts	on	the	immediate	lives	of	people	living	in	different
parts	of	the	UK	and	EU.
Some	key	points	in	our	report	focus	on	how	UK	and	non-UK	citizens’	access	to	healthcare	may	be	impacted	in
different	parts	of	Europe	by	Brexit.	With	further	lockdowns	and	growing	evidence	about	the	chronic	effects	of	Covid-
19,	unequal	access	to	healthcare	in	the	medium	to	long	term	may	profoundly	worsen	already	existing	inequalities.
Getting	the	trade	negotiations	right	will	be	vital	to	providing	a	safe	bridge	from	deep	uncertainty	in	this	period	of
negotiation	and	crisis,	to	a	new	equitable	healthcare	settlement	in	post-Brexit	Europe.
Spain
Estimates	suggest	around	190,000	UK	pensioners	live	in	the	EU,	with	Spain	being	a	common	destination.	These
people	rely	on	EU	rights	to	access	health	care.	Removing	those	entitlements,	and	not	replacing	them	with
something	else,	would	mean	they	would	need	to	have	private	health	insurance.	This	would	impose	a	significant	cost
and	burden,	especially	for	those	with	chronic	or	multiple	conditions.
Article	32	of	the	Withdrawal	Agreement	governs	access	to	medical	care	for	UK	nationals	living	in	EU	member
states	after	31	December	2020.	UK	pensioners	who	have	retired	to	Spain	–	or	anywhere	else	in	the	EU27	–	before
that	date	will	be	able	to	access	the	local	healthcare	system;	while	for	those	who	move	thereafter,	the	EU’s
negotiating	documents	for	the	future	agreement	include	continued	access	to	healthcare	for	pensioners	(only,	not	for
others).	The	UK	negotiation	position	does	not	reciprocate:	EU	nationals	who	retire	to	the	UK	after	the	end	of	the
transition	will	not	have	access	to	the	NHS.
Malta
Small	EU	states	with	close	ties	to	the	UK	may	be	particularly	badly	affected	by	a	trade	deal	that	distances	the	UK
from	EU	regulatory	institutions.	In	Malta,	for	example,	health	authorities	worked	with	the	UK’s	Medicines	and
Healthcare	Products	Regulatory	Agency	(MHRA),	and	60-70%	of	medicines	used	in	Malta	are	supplied	by	UK
bodies.
Some	large	pharmaceutical	companies	may	be	reluctant	to	undertake	the	costs	of	securing	additional	regulatory
compliance	to	supply	the	Maltese	market,	if	ties	to	the	UK	market	dependent	upon	the	EU’s	regulatory	processes
are	weakened.	This	could	have	a	significant	impact	on	the	cost	of	medicines	for	end	users	in	Malta.
Central	and	eastern	Europe
A	number	of	central	and	eastern	EU	member	states	have	close	links	to	the	UK,	with	many	of	their	nationals
currently	living	and	working	in	the	UK.	In	2017	the	Standing	Committee	of	European	Doctors	strongly	urged	the
Barnier	negotiating	team	to	secure	future	mutual	recognition	of	UK	medical	qualifications	in	the	EU.
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This	has	been	achieved	in	part	in	the	Withdrawal	Agreement,	for	ongoing	recognition	of	qualifications	that	were
recognised	before	the	end	of	December	2020.	The	UK	and	EU	negotiation	texts	envisage	a	weaker	form	of	mutual
recognition	of	qualifications	going	forward.
However,	in	practice,	unless	the	UK	departs	significantly	from	EU	standards,	there	may	be	relatively	few	changes.
The	key	difference	will	be	that	individuals	will	no	longer	be	able	to	enforce	rights	to	have	their	qualifications
recognised.	We	may	therefore	see	central	and	eastern	European	medical	professionals	choosing	other	EU
countries,	as	well	as	the	US	or	Australia,	as	alternative	destinations	with	better	systems	for	recognising	medical
qualifications	and	accommodating	migrant	health	professionals.
Ireland
The	potential	impact	of	Brexit	on	Ireland,	and	particularly	the	Irish	border,	has	been	discussed	extensively	since	the
referendum	result.	In	health,	Brexit	may	have	substantive	impacts	given	the	island	of	Ireland	currently	has	a	highly
integrated	cross-border	health	sector,	protected	by	the	Good	Friday/Belfast	Agreement	and	covering	access	to
medical	products,	provision	of	health	services	and	workforce	arrangements.
This	means,	for	example,	that	Irish	citizens	can	receive	treatment	in	Northern	Ireland,	or	that	dentists	from	Northern
Ireland	can	drive	across	the	border	and	work	in	Ireland.	The	Northern	Ireland	Protocol	in	effect	assumes	that
Northern	Ireland	is	within	the	EU’s	customs	territory,	and	so	various	cross-border	health	arrangements,	for	example
cross-border	ambulance	travel,	are	protected.
Nevertheless,	in	terms	of	patterns	of	trade	in	medicinal	products,	devices	and	medical	equipment,	issues	remain
unresolved	in	the	UK-EU	trade	negotiations.	The	threat	remains	that	a	non-comprehensive	free	trade	agreement
between	the	UK	and	EU	would	put	the	cross-border	health	sector	in	Ireland	at	significant	risk.
Getting	a	trade	deal	right	for	health
These	are	just	a	few	specific	instances	where	UK-EU	and	UK-US	trade	agreements	may	impact	healthcare	access
across	Europe.	As	our	report	shows,	however,	if	the	trade	negotiations	are	not	conducted	rigorously	and
transparently	they	may	end	up	exacerbating	inequities	in	access	across	the	UK	and	EU.	This	is	just	when	equity	of
access	is	of	paramount	importance	in	the	fight	against	Covid-19.	This	crisis	has	created	anxiety	across	Europe
about	speeding	up	access	to	vaccines	and	treatments	as	a	priority.
Yet,	there	is	a	danger	that	unless	both	UK	and	EU	negotiating	teams	take	time	on	getting	a	good,	comprehensive
and	fair	deal	for	health,	they	will	unwittingly	pull	the	rug	from	under	our	feet	in	the	fight	against	the	coronavirus.
Please	read	our	comments	policy	before	commenting.
Note:	This	article	first	appeared	at	UK	in	a	Changing	Europe.	It	gives	the	views	of	the	author,	not	the	position	of
EUROPP	–	European	Politics	and	Policy	or	the	London	School	of	Economics.	Featured	image	credit:	Jamie	(CC
BY	2.0)
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